| Authors: |
Lukic A; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Uphill J; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Brown CA; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Beck J; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Poulter M; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Campbell T; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Adamson G; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Hummerich H; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Whitfield J; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Ponto C; Department of Neurology, Georg-August University Göttingen, Göttingen, Germany; German Center for Neurodegenrative Diseases (DZNE), Gottingen, Germany., Zerr I; Department of Neurology, Georg-August University Göttingen, Göttingen, Germany; German Center for Neurodegenrative Diseases (DZNE), Gottingen, Germany., Lloyd SE; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Collinge J; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Mead S; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. Electronic address: s.mead@prion.ucl.ac.uk. |
